Cellectar Biosciences Inc
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; IntoCell Inc; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey. Show More...
-
Website https://www.cellectar.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.26 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -720.0 -620.0 -460.0 -386.0 -175.3 -70.3 -21.4 -10.7 -5.23 -1.84 -1.5 Dividends USD Payout Ratio % * Shares Mil 1.0 3.0 8.0 9.0 Book Value Per Share * USD 815.83 319.57 437.9 154.24 173.88 7.93 7.44 4.56 2.82 1.18 0.44 Free Cash Flow Per Share * USD -5276.73 -677.08 -325.03 -315.98 -275.78 -117.71 -25.96 -9.43 -5.53 -1.83 Return on Assets % -222.14 -114.18 -84.75 -117.88 -80.12 -52.29 -53.93 -106.48 -110.87 -103.23 -135.87 Financial Leverage (Average) 2.04 1.11 1.13 4.01 1.25 4.6 1.21 1.31 1.4 1.55 2.12 Return on Equity % -139.14 -95.12 -181.86 -130.27 -88.66 -86.35 -133.89 -151.08 -151.16 -237.4 Return on Invested Capital % -123.37 -90.82 -168.95 -121.35 -83.26 -83.8 -133.3 -151.02 -146.99 -217.67 Interest Coverage -14.63 -941.36 Current Ratio 2.75 11.55 7.0 0.61 4.44 0.73 7.47 5.17 8.6 4.11 2.58 Quick Ratio 2.67 10.93 6.38 0.53 4.31 0.68 7.01 4.73 8.17 3.83 2.32 Debt/Equity 0.05 0.04 0.26 0.03 0.06 0.05 0.1